To improve efficacy of distant secondary B16 tumors, we treated the mice bearing the secondary tumors with combination therapy: the primary tumor was treated with LIT first, followed by intravenous injection of a PD-1 antibody four times. The gene discussed is PDCD1; the disease is neoplasm.